Seed · 2026-10-27 · AI

Atlas Bio raises $12.5M

AI Score

Amount

$12.5M

Round

Seed

Lead

Creandum, First Momentum Ventures, LEA Partners

Why it matters: Atlas Bio's seed round shows investors backing in silico clinical trials as a replacement for Phase II and animal studies, with one client already skipping animal testing.

Swiss tech-bio startup Atlas Bio launched from stealth with $12.5M total funding.

Participants:: —
Source:: Tech.eu ↗ · Midu summary

Deal Dossier PRO

Pro feature

Deal Dossier for Atlas Bio

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro

Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

More deals with Creandum

Recent AI rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

Midu WeeklyMondays · funding trends and top roundsSee a sample issue →SF WeeklyFridays · San Francisco startups, rounds and eventsSee a sample issue →

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing